Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Statistical abstract. Department of Census and Statistics, Sri Lanka. 2009. http://www.statistics.gov.lk/abstract2009/Pages/index.htm .
Athuraliya TN, Abeysekera DT, Amerasinghe PH, Kumarasiri PV, Dissanayake. Prevalence of chronic kidney disease in two tertiary care hospitals: high proportion of cases with uncertain aetiology. Ceylon Med. 2009;54:23–5.
World Health Organization (WHO) country office Sri Lanka. News letters. http://www.whosrilanka.org/EN/Section1_76.htm . Accessed 20 Dec 2010.
Bandara JMRS, Senevirathna DMA, Dasanayake DMRSV, Herath V, Bandara JMRP, Abeysekara T, Rajapaksha KH. Chronic renal failure in cascade irrigation systems in Sri Lanka associated with elevated dietary cadmium levels, rice and fresh water fish (Thilapia). Environ Geochem Health. 2008;30:465–78.
Bandara JM, Wijewardena HV, Liyanege J, Upul MA, Bandara. Chronic renal failure in Sri Lanka caused by elevated dietary cadmium: Trojan horse of the green revolution. Toxicol Lett. 2010;198:33–9.
Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R, Hittarage A. Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease. Trans R Soc Trop Med Hyg. 2007;101:1013–7.
Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS. Chronic kidney disease associated with environmental toxins and exposure. Adv Chronic Kidney Dis. 2010;17:254–64.
Chandrajith R, Nanayakkara S, Itai K, Aturaliya TN, Dissanayake CB, Abeysekara T, Harada K, Watanabe T, Koizumi A. Chronic kidney disease of uncertain aetiology (CKDuee) in Sri Lanka: geographic distribution and environmental implications. Environ Geochem Health. 2011;33:267–78.
Järup L, Akesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol. 2009;238:201–8.
Moriguchi J, Inoue Y, Kamiyama S, Horiguchi M, Murata K, Sakuragi S, Fukui Y, Ohashi F, Ikeda M. N-acetyl-beta-d-glucosaminidase (NAG) as the most sensitive marker for tubular dysfunction for monitoring residents in non-polluted areas. Toxicol Lett. 2009;190:1–8.
National Kidney Foundation (NKF). KDOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. http://www.kidney.org/professionals/KDOQI/guidelines_ckd/toc.htm . Accessed 20 Dec 2010.
Kooman JP. Estimation of renal function in patients with chronic kidney disease. J Magn Reson Imaging. 2009;30:1341–6.
Koizumi A, Harada KH, Inoue K, Hitomi T, Yang HR, Moon CS, Wang P, Hung NN, Watanabe T, Shimbo S, Ikeda M. Past, present and future of environmental specimen banks. Environ Health Prev Med. 2009;14:307–18.
Koizumi A Yoshinaga T, Harada K, Inoue K, Morikawa, Muroi J, Inoue S, Eslami B, Fujii S, Fujimine Y, Hachiya N, Koda S, Kusaka Y, Murata K, Nakatsuka H, Omae K, Saito N, Shimbo S, Takenaka K, Takeshita T, Todoriki H, Wada Y, Watanabe T, Ikeda M. Assessment of human exposure to polychlorinated and polybrominated diphenyl ethers in Japan using early 1980s and mid 1990s archive samples. Environ Res. 2005; 99:31–9.
Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008;40:695–701.
Ikeda M, Ohashi F, Fukui Y, Takada S, Moriguchi J, Ezaki T. Changes in tubular dysfunction marker levels in parallel with the levels of copper, rather than cadmium, in urine of middle-aged women in non-polluted areas. Int Arch Occup Environ Health. 2007;80:171–83.
Yamagami T, Suna T, Fukui Y, Ohashi F, Takada S, Sakurai H, Aoshima K, Ikeda M. Biological variations in cadmium, alpha 1-microglobulin, beta 2-microglobulin and N-acetyl-beta-d-glucosaminidase in adult women in a non-polluted area. Int Arch Occup Environ Health. 2008;81:263–71.
Ikeda M, Ezaki T, Tsukahara T, Moriguchi J, Furuki K, Fukui Y, Ukai SH, Okamoto, Sakurai H. Critical evaluation of alpha1- and beta2-microglobulins in urine as markers of cadmium-induced tubular dysfunction. Biometals. 2004;17:539–41.
Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishi M, Kido T, Nishijo M, Nakagawa H, Nogawa K. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-d-glucosaminidase in cadmium nonpolluted regions in Japan. Environ Res. 2006;101:401–6.
Uno T, Kobayashi E, Suwazono Y, Okubo Y, Miura K, Sakata K, Okayama A, Ueshima H, Nakagawa H, Nogawa K. Health effects of cadmium exposure in the general environment in Japan with special reference to the lower limit of the benchmark dose as the threshold level of urinary cadmium. Scand J Work Environ Health. 2005;31:307–15.
Bernard A. Cadmium and its adverse effects on human health. Indian J Med Res. 2008;128:557–64.
Vincent C, Marceau M, Blangarin P, Bouic P, Madjar JJ, Revillard JP. Purification of alpha 1-microglobulin produced by human hepatoma cell lines. Biochemical characterization and comparison with alpha 1-microglobulin synthesized by human hepatocytes. Eur J Biochem. 1987;165:699–704.
Yu H, Yanagisawa Y, Forbes MA, Cooper EH, Crockson RA, MacLennan ICM. Alpha-1-microglobulin: an inhibitor protein for renal tubular function. J Clin Pathol. 1983;36:253–9.
Franko A, Budihna MV, Dodic-Fikfak M. Long-term effects of elemental mercury on renal function in miners of the Idrija Mercury Mine. Ann Occup Hyg. 2005;49:521–7.
Pergande M, Jung K, Percht S, Fels LM, Herbort C, Stolte H. Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant. 1994;9:613–8.
Penders J, Delanghe JR. Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta. 2004;346:107–18.
Stefanović V, Polenaković M. Fifty years of research in Balkan endemic nephropathy: where are we now? Nephron Clin Pract. 2009;112:c51–6.
Toncheva D, Dimitrov T. Genetic predisposition to Balkan endemic nephropathy. Nephron. 1996;72:564–9.